Emanuel DeNoia

Lack of a Pharmacokinetic Effect of Raltegravir on Midazolam: In Vitro/In Vivo Correlation

Marian Iwamoto, Kelem Kassahun, Matthew D. Troyer et al. · The Journal of Clinical Pharmacology · 2007 · 80 citations

Vitro/in Vivo Correlation, Pharmacotherapy, Antiviral Drug +16

Lack of a Clinically Meaningful Pharmacokinetic Effect of Rifabutin on Raltegravir: In Vitro/In Vivo Correlation

Diana M. Brainard, Kelem Kassahun, Larissa Wenning et al. · The Journal of Clinical Pharmacology · 2010 · 35 citations

Molecular Pharmacology, Plasma Levels, Medicine +13

A Phase I Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Recombinant Human Hyaluronidase PH20 Administered Intravenously in Healthy Volunteers

Marie A. Printz, Samuel S. Dychter, Emanuel DeNoia et al. · Current Therapeutic Research · 2020 · 20 citations · Full text

Tolerability and Pharmacokinetic Properties of Ondansetron Administered Subcutaneously With Recombinant Human Hyaluronidase in Minipigs and Healthy Volunteers

Samuel S. Dychter, Rena Harrigan, Jesse Bahn et al. · Clinical Therapeutics · 2014 · 19 citations

Molecular Pharmacology, Translational Medicine, Recombinant Human Hyaluronidase +5

Leveraging a Clinical Phase Ib Proof‐of‐Concept Study for the GPR40 Agonist MK‐8666 in Patients With Type 2 Diabetes for Model‐Informed Phase II Dose Selection

AW Krug, Pavan Vaddady, RA Railkar et al. · Clinical and Translational Science · 2017 · 16 citations · Full text